- Article
MiR-486-5p Targets CD133+ Lung Cancer Stem Cells through the p85/AKT Pathway
- Massimo Moro,
- Orazio Fortunato,
- Giulia Bertolini,
- Mavis Mensah,
- Cristina Borzi,
- Giovanni Centonze,
- Francesca Andriani,
- Daniela Di Paolo,
- Patrizia Perri and
- Mattia Boeri
- + 3 authors
Despite improvements in therapies and screening strategies, lung cancer prognosis still remains dismal, especially for metastatic tumors. Cancer stem cells (CSCs) are endowed with properties such as chemoresistance, dissemination, and stem-like featu...